<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:54:06Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11162" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11162</identifier><datestamp>2026-10-18T21:13:15Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Plasma and Milk Pharmacokinetics and Estimated Milk Withdrawal Time of Tolfenamic Acid in Lactating Sheep</dc:title><dc:creator>Corum, Orhan</dc:creator><dc:creator>Uney, Kamil</dc:creator><dc:creator>Coskun, Devran</dc:creator><dc:creator>Durna Corum, Duygu</dc:creator><dc:creator>Cetin, Gul</dc:creator><dc:creator>Elmas, Muammer</dc:creator><dc:subject>lactating sheep</dc:subject><dc:subject>milk</dc:subject><dc:subject>pharmacokinetics</dc:subject><dc:subject>tolfenamic acid</dc:subject><dc:subject>withdrawal time</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Antifibrinolytic Agents</dc:subject><dc:subject>Cross-Over Studies</dc:subject><dc:subject>Female</dc:subject><dc:subject>Lactation</dc:subject><dc:subject>ortho-Aminobenzoates</dc:subject><dc:subject>Sheep</dc:subject><dc:subject>Sheep, Domestic</dc:subject><dc:subject>nonsteroid antiinflammatory agent</dc:subject><dc:subject>anthranilic acid derivative</dc:subject><dc:subject>antifibrinolytic agent</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>area under the curve</dc:subject><dc:subject>Article</dc:subject><dc:subject>blood cell count</dc:subject><dc:subject>clinical trial</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>dairy cattle</dc:subject><dc:subject>drug blood level</dc:subject><dc:subject>drug half life</dc:subject><dc:subject>fever</dc:subject><dc:subject>high performance liquid chromatography</dc:subject><dc:subject>linear regression analysis</dc:subject><dc:subject>mastitis</dc:subject><dc:subject>maximum plasma concentration</dc:subject><dc:description>Objective: This study aimed to investigate the plasma and milk pharmacokinetics, as well as the withdrawal time (WT) from milk of tolfenamic acid (2 and 4 mg/kg) following intravenous (IV) administration to eight healthy lactating Akkaraman sheep. Methods: The trial was conducted in two periods in accordance with a crossover pharmacokinetic design. The concentrations of tolfenamic acid in the plasma and milk were determined using high-pressure liquid chromatography and evaluated using non-compartmental analysis. The WT of tolfenamic acid in milk was calculated using the WT 1.4 software. Results: Compared to the 2 mg/kg dose, plasma volume of distribution at steady state (from 0.43 to 0.50 L/kg), terminal elimination half-life (from 2.41 to 4.14 h) and dose-normalized area under the plasma concentration–time curve (AUC0−∞, from 9.46 to 30.11 h µg/mL) increased, whereas total body clearance (from 0.21 to 0.13 L/h/kg) decreased at the 4 mg/kg dose. The peak milk concentration (Cmax) and AUC0−∞ values in milk were 0.26 µg/mL and 0.28 h µg/mL, respectively, for 2 mg/kg, and 0.43 µg/mL and 0.55 h µg/mL, respectively, for 4 mg/kg. Although the dose-normalized Cmax of milk decreased depending on the dose, no difference was observed in dose-normalized AUC0−∞. The AUC0−∞ milk/AUC0−∞ plasma ratio was 0.03 for 2 mg/kg and 0.02 for 4 mg/kg. The WT values calculated for milk at dosages of 2 and 4 mg/kg were 3 and 4 h, respectively. Conclusions: A decrease in plasma elimination and an increase in plasma concentration of tolfenamic acid were observed depending on the dose. Tolfenamic acid lowly passed into sheep's milk at 2 and 4 mg/kg doses. This study may provide valuable information for clinicians’ decision-making processes. © 2024 The Author(s). Veterinary Medicine and Science published by John Wiley &amp; Sons Ltd.</dc:description><dc:publisher>John Wiley and Sons Inc</dc:publisher><dc:date>2024</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/11162</dc:identifier><dc:identifier>https://doi.org/10.1002/vms3.70047</dc:identifier><dc:identifier>2053-1095</dc:identifier><dc:language>en</dc:language><dc:relation>Veterinary Medicine and Science</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11162</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>